key: cord-0708677-bfmcqcq1
authors: Wendisch, Daniel; Dietrich, Oliver; Mari, Tommaso; von Stillfried, Saskia; Ibarra, Ignacio L.; Mittermaier, Mirja; Mache, Christin; Chua, Robert Lorenz; Knoll, Rainer; Timm, Sara; Brumhard, Sophia; Krammer, Tobias; Zauber, Henrik; Hiller, Anna Luisa; Pascual-Reguant, Anna; Mothes, Ronja; Bülow, Roman David; Schulze, Jessica; Leipold, Alexander M.; Djudjaj, Sonja; Erhard, Florian; Geffers, Robert; Pott, Fabian; Kazmierski, Julia; Radke, Josefine; Pergantis, Panagiotis; Baßler, Kevin; Conrad, Claudia; Aschenbrenner, Anna C.; Sawitzki, Birgit; Landthaler, Markus; Wyler, Emanuel; Horst, David; Hippenstiel, Stefan; Hocke, Andreas; Heppner, Frank L.; Uhrig, Alexander; Garcia, Carmen; Machleidt, Felix; Herold, Susanne; Elezkurtaj, Sefer; Thibeault, Charlotte; Witzenrath, Martin; Cochain, Clément; Suttorp, Norbert; Drosten, Christian; Goffinet, Christine; Kurth, Florian; Schultze, Joachim L.; Radbruch, Helena; Ochs, Matthias; Eils, Roland; Müller-Redetzky, Holger; Hauser, Anja E.; Luecken, Malte D.; Theis, Fabian J.; Conrad, Christian; Wolff, Thorsten; Boor, Peter; Selbach, Matthias; Saliba, Antoine-Emmanuel; Sander, Leif Erik
title: SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
date: 2021-11-27
journal: Cell
DOI: 10.1016/j.cell.2021.11.033
sha: 76419d11545f3db9d9faba393e4d9227641e665d
doc_id: 708677
cord_uid: bfmcqcq1

COVID-19-induced ‘acute respiratory distress syndrome’ (ARDS) is associated with prolonged respiratory failure and high mortality, but the mechanistic basis of lung injury remains incompletely understood. Here, we analyzed pulmonary immune responses and lung pathology in two cohorts of patients with COVID-19 ARDS using functional single cell genomics, immunohistology and electron microscopy. We describe an accumulation of CD163-expressing monocyte-derived macrophages that acquired a profibrotic transcriptional phenotype during COVID-19 ARDS. Gene set enrichment and computational data integration revealed a significant similarity between COVID-19-associated macrophages and profibrotic macrophage populations identified in idiopathic pulmonary fibrosis. COVID-19 ARDS was associated with clinical, radiographic, histopathological, and ultrastructural hallmarks of pulmonary fibrosis. Exposure of human monocytes to SARS-CoV-2, but not Influenza A virus or viral RNA analogs, was sufficient to induce a similar profibrotic phenotype in vitro. In conclusion, we demonstrate that SARS-CoV-2 triggers profibrotic macrophage responses and pronounced fibroproliferative ARDS.

'Severe acute respiratory syndrome coronavirus-2' (SARS-CoV-2), the causative agent of 'coronavirus disease 2019' initially infects and replicates in epithelial cells of the upper respiratory tract (Hoffmann et al. 2020; Wölfel et al. 2020) . While SARS-CoV-2 infection causes mild respiratory disease in the majority of individuals, approximately 5% of patients develop acute respiratory distress syndrome (ARDS), which requires prolonged respiratory support and is associated with high mortality (Osuchowski et al., 2021; Richardson et al., 2020) . ARDS is a clinical syndrome defined as a combination of acute hypoxemia and bilateral radiographic opacities not explained by cardiac dysfunction or volume overload, occurring within seven days after a known clinical insult or onset of new respiratory symptoms (Ferguson et al., 2012) . The pathophysiology of ARDS is typically viewed as a bi-or triphasic response to lung injury. The initial 'exudative phase' is characterized by injury-induced and myeloid cell propagated diffuse alveolar damage, barrier breakdown, and edema. It is followed by a second 'proliferative phase', marked by epithelial cell repair, reabsorption of fluid, and restoration of alveolar integrity. The third 'fibrotic phase' only occurs in a subset of patients, and it is associated with respiratory failure and high mortality (Thompson et al., 2017) .

COVID-19 induced ARDS requires protracted mechanical ventilation or extracorporeal membrane oxygenation (ECMO) and it is associated with high mortality (Barbaro et al., 2020; Hasan et al., 2020; Henry and Lippi, 2020) . Respiratory failure and ARDS typically develop in the second week after symptom onset, in spite of declining viral loads (Barbaro et al., 2020; He et al., 2020; Jones et al., 2021; Wölfel et al., 2020) . The delayed onset suggests that ARDS in COVID-19 is driven by secondary events, including inappropriate immune responses (Carsana et al., 2020; D'Alessio and Heller, 2020; Polak et al., 2020) . Supporting this notion, dysregulated systemic and mucosal immune responses, particularly within the myeloid cell compartment, have been observed in severe COVID-19 (Bharat et al., 2020; Carsana et al., 2020; Chua et al., 2020; D'Alessio and Heller, 2020; Grant et al., 2021; Liao et al., 2020; Messner et al., 2020; Schulte-Schrepping et al., 2020; Szabo et al., 2021) . It has been repeatedly suggested that a subset of COVID-19 patients develops a detrimental hyperinflammatory condition and monocytes and macrophages have been proposed as critical mediators of this inflammatory syndrome (Blanco-Melo et al., 2020; Mehta et al., 2020; Webb et al., 2020) . In contrast, systematic analysis of severe COVID-19 showed that the levels of inflammatory cytokines were one or two orders of magnitude lower than in comparable cohorts of non-COVID-19 induced ARDS (Calfee et al., 2014; Leisman et al., 2020; Sinha et al., 2020) , calling into question the concept of a "cytokine storm" or "inflammatory macrophage" syndrome (Remy et al., 2020) . In line with this observation, monocyte and neutrophil J o u r n a l P r e -p r o o f 7 ARDS (Figure 2A and S2A-D, Table S1 ). Consistent with post mortem analysis of lung tissue (Figure 1) , and in agreement with previous reports (Grant et al., 2021; Liao et al., 2020; Szabo et al., 2021) , we identified a dominant proportion of myeloid cells, particularly neutrophils and monocytes/macrophages (Figure 2A and S2E, Table S2 ). SARS-CoV-2 transcripts were primarily detected within monocytes/macrophages ( Figure S2C ).

Detailed analysis revealed six monocyte/macrophage populations with distinct gene expression profiles (Figure 2B-D and S2F ,G and Table S2 ). FCN1-Monocytes expressed high levels of Ficolin-M (FCN1) and CD14 but low levels of FCGR3A, encoding for CD16a ( Figure 2C, D) . 'FCN1-Monocytes' were marked by high expression of alarmins (S100A8, S100A12), selected inflammatory cytokines (IL1B, IL6, CXCL8) and CCR2, the receptor for Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) ( Figure 2C, 2D and S2F) . Notably, FCN1-Monocytes also expressed TGFB1, encoding for TGF-β, a master regulator of wound healing and repair, and its downstream target TGFBI. The adjacent 'Mono/Mφ' population showed a less distinct phenotype, indicative of a transitory differentiation state. (Figure 2D and S2F). 'Mono/Mφ' and the adjacent monocyte-derived macrophage population expressed high levels of SPP1, encoding for Osteopontin, a multifunctional matricellular protein and cytokine expressed in macrophages in various pathologies (Rittling, 2011) . The SPP1 + macrophage population was defined by high expression of CD163 and LGMN, encoding for Legumain, and is henceforth referred to as 'CD163/LGMN-Mφ' (Figure 2C,D) . We also identified three types of alveolar macrophages (AMφ1, AMφ2, and proliferating AMφ), characterized by high expression of FABP1, FABP4, and MARCO ( Figure 2D) , characteristic for AMφ (Arredouani et al., 2005) . AMφ-2 expressed high levels of TGF-β family member 'Inhibin beta A' (INHBA) while 'proliferating-AMφ' expressed cell cycle related genes (MKI67, (Keenan et al., 2019) predicted SPI1 (encoding PU.1) as regulatory in FCN1-Monocytes, and TFEC and GLMP for CD163/LGMN-Mφ, while nuclear receptor PPARγ, involved in alveolar macrophage differentiation, lipid homeostasis and repression of inflammatory macrophage responses (Kidani and Bensinger, 2012; Schneider et al., 2014) , was predicted to control transcription in AMφ1 and AMφ2 ( Figure S2H and Table S2 ).

We corroborated these findings on a second set of BAL samples from patients with severe COVID-19 ARDS, revealing similar macrophage populations (Figure S2I-O) . FCN1-Monocytes, Mono-Mφ and CD163/LGMN-Mφ were dominant in the first four weeks of COVID-19 ARDS, and AMφ1 and AMφ2 repopulated the alveolar compartment in the later stages of the disease (Figure 2E) . For further validation, we compared the transcriptional phenotypes of macrophages identified in our cohort with previously published transcriptomes of pulmonary macrophages in COVID-19 (Grant et al., 2021; Liao et al., 2020) . We found highly similar macrophage profiles in all three COVID-19 datasets ( Figure 2F) , confirming that the accumulation of monocyte-derived macrophages with damage response-and tissue repair signatures is a common feature of COVID-19 ARDS.

Pulmonary macrophages in COVID-19 adopt a profibrotic phenotype Misguided damage repair-and wound healing responses by monocytes and macrophages play a key role in tissue remodeling, scarring, and fibrosis (Adler et al., 2020; Henderson et al., 2020; Misharin et al., 2017; Satoh et al., 2017) . Macrophages within fibrotic niches in pulmonary fibrosis express shared transcriptional programs (Aran et al., 2019; Ayaub et al., 2021; Joshi et al., 2020; Morse et al., 2019; Reyfman et al., 2019) . We therefore assessed the transcriptional similarity between monocytes and macrophages in severe COVID-19 and macrophages from four published data sets of pulmonary fibrosis (Adams et al., 2020; Ayaub et al., 2021; Reyfman et al., 2019; Morse et al, 2019) . We computed cell-based scores based on gene set expression and assessed differences across populations ( Figure 3A,S3A ), in addition to over-representation analysis between gene sets ( Figure 3B ). These comparisons indicated that the CD163/LGMN-Mφ population closely resembles IPF-specific macrophage phenotypes, while FCN1-Mono, and AMφ1 and AMφ2 were more similar to homeostatic monocytes and alveolar macrophages, respectively (Figures 3A,B, S3A and Table S3 ).

In order to directly compare the cellular transcriptomes of COVID-19-associated and IPFassociated macrophages, we integrated our scRNA-seq data along with another COVID-19 dataset (Bharat et al., 2020) with two scRNA-seq datasets containing IPF, COPD and control samples (Adams et al., 2020; Morse et al., 2019) using single-cell variational inference (scVI) J o u r n a l P r e -p r o o f (Lopez et al., 2018; Wolf et al., 2018) (Figure 3C-F Both IPF-and COVID-19-associated macrophages expressed genes with well-known pathogenic functions in fibrosis, such as SPP1, TGFB1, TGFBI, LGMN, and CCL18 ( Figure   S3D ). Proximity analysis based on a k-nearest neighbours classifier revealed a significant similarity of CD163/LGMN-Mφ and proliferating-AMφ with IPF-associated macrophages (relative fractions 0.66, 0.83, respectively; adjusted p<0.0001; Fisher's exact test, one-tailed) ( Figure 3F ). AMφ2 (0.63) and FCN1-Mono (0.47), which resemble steady-state alveolar macrophages and monocytes, were embedded in proximity to macrophages from healthy lungs ( Figure 3F and S3B,C). Similar results were obtained analyzing a publiched COVID-19 dataset (Bharat et al., 2020) , confirming that monocyte-derived macrophages (MoM3), which corresponded to CD163/LGMN-Mφ ( Figure 2F ), showed high similarity with IPF-associated macrophages ( Figure S3C ,E).

Gene set over-representation, scRNA-seq data integration, and proximity analyses revealed that pulmonary CD163/LGMN-Mφ in COVID-19 showed significant transcriptional similarity with macrophages found in IPF. The data indicate that newly recruited monocyte-derived macrophages in COVID-19 adopt a fibrosis-associated phenotype.

ARDS To further investigate the association of pulmonary macrophage populations and fibrotic responses, we analyzed post mortem lung tissue samples from patients with fatal COVID-19.

Using snRNA-seq, we identified 15 distinct populations of lung cells based on canonical marker genes ( Figure 4A ) . We found macrophage phenotypes similar to those described in BAL (Figure 4B and S4A) as well as pericytes, smooth muscle cells, fibroblasts, and myofibroblasts ( Figure 4C and S4B) . Fibroblasts and myofibroblasts showed strong upregulation of ECM protein encoding genes in COVID-19, particularly in later stages of the disease (days 34-82), indicating a strong fibrotic response ( Figure S4C ). We next inferred communication networks between macrophages and mesenchymal cells using the ligand-receptor interaction tool CellChat (Jin et al., 2021) . The analysis revealed strong interactions of CD163/LGMN-Mφ, and to a lesser extent Mono/Mφ with myofibroblasts, fibroblasts and pericytes ( Figure 4D ). The interaction strength was increased at later time points (days 34-82) relative to earlier stages of the disease (days 7-21) ( Figure 4D ).

Information flow analysis showed an involvement of potent profibrotic pathways, including Col, FGF (fibroblast growth factor), TGFB1, and SPP1, among others ( Figure 4E ).

We next assessed tissue distribution of SM22 + myofibroblasts and CD68 + macrophages by IF in autopsy lung samples. Myofibroblasts were expanded compared to non-COVID-19 controls and macrophages were frequently found in close proximity to SM22 + loci (Figure 4F and S4D) .

We also noted a marked co-localization of CD163 + macrophages and collagen deposits ( Figure 4G and S4E,F) , however expansion of both collagen areas and macrophages increases the probability of colocalization.

In summary, we found that pulmonary macrophages colocalized with collagen and myofibroblast loci and engaged in strong signal interactions with myofibroblasts, fibroblasts and pericytes. Interactions between CD163/LGMN-Mφ and mesenchymal cells may thus contribute to a highly profibrotic milieu in COVID-19 ARDS.

COVID-19 is associated with pronounced fibroproliferative ARDS Identification of fibrosis-associated transcriptional signatures in macrophages and their interactions with mesenchymal cells in COVID-19 ARDS, prompted us to assess evidence of lung fibrosis in COVID-19. We analyzed a cohort of 16 patients with severe COVID-19-induced ARDS (60.5 years old (IQR 16.3), 94% male), defined by the requirement of veno-venous (vv)ECMO (Table S4) . Mean duration of vvECMO therapy was 36.5 days (IQR 57), median time from start of mechanical ventilation to initiation of vvECMO was 12.5 days (IQR 10), 68.8% of patients could be weaned from vvECMO, overall mortality was 56.3%. Patients in this cohort had a PaO2 /FiO2 ratio of 98.3 mmHg (IQR 56.9) (Figure S5A) , and a median partial pressure of PaCO2 of 71.5 mmHg (IQR 15.9) (Figure S5B) , measured two to four hours prior to initiation of vvECMO, indicating severe ARDS. The elevated PaCO2, while the patients were ventilated with a supranormal minute volume (8.7 l/min ;IQR 3.5), indicated a pathologically elevated dead space. This is consistent with fibroproliferative tissue remodeling in ARDS (Hendrickson et al., 2015) . Vital capacity (VCin) decreased continuously in severe ARDS on vvECMO support, indicating a progressive restrictive ventilatory defect ( Figure 5A ). To assess radiographic correlates of these restrictive defects, we compared the first available CT scan to images during severe ARDS on vvECMO treatment and to the last available CT scan. The majority of ARDS patients showed multilocular bilateral ground glass opacities (GGO) and consolidations in the first available CT scan, typical for acute COVID-19 pneumonia ( Figure   5B and S5C). Over the course of the disease, CT imaging revealed progressive consolidation and reticulation, indicative of fibroproliferative ARDS. Patients who deceased on vvECMO J o u r n a l P r e -p r o o f failed to resolve consolidations and fibrous stripes, whereas patients who could be successfully weaned from vvECMO and ultimately recovered showed a gradual resolution of fibrosis with residual reticulations in the last available CT (Figure 5B and S5C) , which was also reflected in a normalized PaCO2 and PaO2/FiO ratio ( Figure S5B ).

To assess the extent of fibrotic tissue remodelling, we analyzed 14 autopsy samples and one non-autopsy sample of 15 patients with COVID-19 ARDS (cohort 2) and seven non-COVID-19 samples from five autopsies and two non-autopsy cases (controls) (Figure S1A ).

Histopathological evaluation (H&E) revealed extensive diffuse alveolar damage and edema early on and increasing fibroproliferative tissue remodeling and fibrotic foci at later time points after onset of ARDS (Figure 5C and S5D) . Pulmonary fibrosis, scored by two independent experienced pathologists using a well-established semiquantitative fibrosis score (Ashcroft et al., 1988) , was significantly increased in COVID-19 ARDS ( Figure 5D ). Pulmonary fibrosis is characterized by interstitial fibroblast proliferation and deposition of ECM proteins, particularly collagen. Here, we found extensive interstitial collagen type 1, 3 and 4 deposition in COVID-19-associated ARDS (Figure 5C ,D, and Figure S5D -F).

Transmission EM analysis of autopsy lung samples revealed thickened alveolar septa due to interstitial edema and accumulation of connective tissue fibers, in particular collagen fibrils and elastic fibers ( Figure 5E ). The alveolar epithelium was partly desquamated resulting in a denuded alveolar epithelial basal lamina. Infoldings of the denuded basal laminae represent an ultrastructural characteristic of alveolar collapse and collapse induration and these were frequently found in severe COVID-19 (Ochs et al., 2021) . Collapse indurations were surrounded by deposits of collagen fibrils and elastic fibers. Interstitial cells within the thickened septa had a foamy appearance, containing membrane-bound vesicles of varying size. The vesicle contents appeared largely homogenous with low to moderate electron density. A distinction between interstitial macrophages and activated fibroblasts is difficult based solely on morphology, which is why we refer to these cells simply as interstitial cells.

Alveolar macrophages also had a foamy appearance, but their vesicles also contained stacks of lipid lamellae, a typical feature in alveolar macrophages.

In conclusion, we revealed exacerbated fibroproliferative responses with clear ventilatory, radiographic, histological and ultrastructural features of pulmonary scarring and fibrosis during severe COVID-19-associated ARDS.

J o u r n a l P r e -p r o o f SARS-CoV-2 triggers a fibrosis associated transcriptional profile in monocytes Key mediators of wound healing and fibrosis, including TGF-β, are induced in phagocytes upon tissue damage and uptake of apoptotic cells (Huynh et al., 2002) . Profibrotic damage response signatures in macrophages may therefore result from extensive lung injury during ARDS and ventilator-induced lung injury. As SARS-CoV-2 transcripts were found in macrophages ( Figure 1E , 2B) and particularly in CD163/LGMN-Mφ (Figure 2C) , we tested whether viral contact might directly elicit fibrosis-associated signatures in monocytes. We stimulated classical (CD14 + CD16 -) monocytes isolated from healthy donors with SARS-CoV-2 for 18 hours and analyzed the transcriptional responses by scRNA-seq with multiplexing of experimental conditions (by hashtag oligos, HTO) and donors (by single nucleotide polymorphism, SNP) to minimise batch effects ( Figure 6A and S6A,B) . We included ligands of viral RNA-sensors, retinoic acid-inducible gene I (RIG-I) and melanoma differentiationassociated protein 5 (MDA5) agonist 3'-ppp-hairpin-RNA (3p-hpRNA), and R848, a dual agonist of Toll-like receptor (TLR)-7/-8, for comparison. We observed distinct responses to 3p-hpRNA, R848, and SARS-CoV-2 ( Figure 6B , Table S5 ). The monocyte response to SARS-CoV-2 was distinct, however, partially overlapping with 3p-hpRNA stimulation, indicating the potential of SARS-CoV-2 to elicit modest type-I IFN responses via RIG-I-like receptors ( Figure   6C and S6B,C). Notably, several genes characteristic of pulmonary macrophages identified both in COVID-19 and in lung fibrosis, including MRC1, CD163, MERTK, LGMN, and MMP9 were specifically induced upon exposure to SARS-CoV-2 ( Figure 6C , S6D and Table S5 ).

SARS-CoV-2 also induced TGF-β family genes NRP1 and TGFBI (Figure 6C and S6D) .

NRP1 promotes host cell binding and entry of SARS-CoV-2 (Cantuti-Castelvetri et al., 2020; Daly et al., 2020) , yet, despite abundant viral transcripts in SARS-CoV-2-stimulated monocytes, we found no evidence of productive infection (unpublished data and Figure S6A ).

In contrast to R848, SARS-CoV-2 stimulation induced only limited expression of IL1B and no IL6 (Figure 6C and S6D) . Transcription factor predictions revealed an overlap of SARS-CoV-2-stimulated monocytes with pulmonary CD163/LGMN-Mφ macrophages in COVID-19 ARDS, including a predicted involvement of TFEC, GLMP and HLX ( Figure S2H , S6E, Table S5 ).

Given the overlap of gene expression in SARS-CoV-2-exposed monocytes and CD163/LGMN-Mφ, we assessed the potential enrichment of IPF-associated macrophage gene sets. Fibrosis-associated macrophage gene signatures were specifically enriched in SARS-CoV-2-exposed monocytes, but not in 3'-hpRNA-, R848-stimulated, or unstimulated control monocytes (Figure 6D and S6F) . We found a high similarity of gene expression in SARS-CoV-2-stimulated monocytes and IPF-associated macrophages, including IPF-specific J o u r n a l P r e -p r o o f clusters ( Figure 6E) . These results indicate that SARS-CoV-2 directly triggers a transcriptional profile in human monocytes that resembles fibrosis-associated pulmonary macrophages. SARS-CoV-2 triggers a profibrotic proteome profile in monocytes To validate and specify these findings, we performed multiplexed quantitative shotgun proteomics, which can provide data with high relevance for cellular phenotypes (Buccitelli and Selbach, 2020) . Monocytes isolated from healthy donors were stimulated with SARS-CoV-2 or influenza A virus (IAV,H3N2), which has been well-studied at the proteome level (Bogdanow et al., 2019; Sadewasser et al., 2017) (Figure 7A ). Analysis at 1, 3, and 18 hours post infection (hpi) reproducibly quantified 6,951 proteins and 5,299 phosphorylation sites in two replicates from four donors ( Figure S7A ). Consistent with the ability of IAV to productively infect monocytes (Cline et al., 2017) , we found an increase of IAV proteins over time ( Figure 7B ).

In contrast, SARS-CoV-2 proteins remained constant or decreased ( Figure 7B ). Only SARS-CoV-2 M protein (VME1) showed a moderate increase, suggesting some residual viral transcription and translation ( Figure 7B, S7B) .

SARS-CoV-2 and IAV induced distinct changes in the host proteome, particularly at 18 hpi ( Figure 7C and Table S6 ). To identify SARS-CoV-2 specific responses, we performed gene set enrichment analysis on SARS-CoV-2 over IAV protein ratios (Subramanian et al., 2005) . SARS-CoV-2 specific gene sets were related to innate immunity, antiviral defense and RIG-I like receptor signalling, while IAV induced viral gene expression-and replication-associated genes ( Figure 7D and Table S6 ). Importantly, genes related to wound healing and fibrosis were upregulated in response to SARS-CoV-2 ( Figure 7D ).

For visualization, we mapped the proteomic data to antiviral and profibrotic pathways, revealing marked differences in the responses to the IAV and SARS-CoV-2 ( Figure 7E and S7C). SARS-CoV-2 induced upregulation of RIG-I-like receptors, ds-RNA sensors as well as scavenger receptors and related membrane proteins. Additionally, we observed an upregulation of transcription factors related to inflammation (NFkB, IRF7) and macrophage differentiation (MAFB, CEBPB) ( Figure 7E, S7C) . MAFB was highly expressed in CD163/LGMN-Mφ ( Figure 2D ) and it has been identified as a specific marker of macrophages in pulmonary fibrosis (Aran et al., 2019) . CEBPB activation was predicted in SARS-CoV-2stimulated monocytes ( Figure S6E ) and it has been shown to license differentiation of profibrotic macrophages (Satoh et al., 2017) . Additionally, we observed upregulation of the transcriptionally active longer isoforms (LAP*/LAP) and downregulation of the shorter J o u r n a l P r e -p r o o f inhibitory (LIP) isoform of CEBPB ( Figure S7D ). This isoform switch occurs via alternative translation initiation from the same mRNA and is only detectable at the protein level (Descombes and Schibler, 1991) . Increased LAP:LIP ratio mediates macrophage differentiation (Calkhoven et al., 2000; Huber et al., 2012) . Translation of the LAP*/LAP isoform is induced upon activation of PKR, consistent with its induction by SARS-CoV-2 ( Figure 7E ). We further identified increased phosphorylation of specific sites on CEBPB and IRF7, suggesting an enhanced transcriptional activity ( Figure 7E , S7E,F).

Consistent with in vivo transcriptomic data (Table S2) Figure 7E ). Similar to the transcriptomic data, IPF-specific macrophage signatures 'IPFe-Mφ' (Ayaub et al., 2021) , 'SPP1+Mφ-IPF' (Morse et al., 2019) , 'Mφ-fibrosis' (Reyfman et al., 2019) were highly enriched in monocytes stimulated with SARS-CoV-2 for 18h, but not in IAVinfected cells (Figure 7F and S7H) . Thus, detection of SARS-CoV-2, but not IAV, by human classical monocytes constitutes a trigger of fibrosis-associated differentiation programs.

Pathomechanisms of severe COVID-19 associated ARDS remain incompletely understood . Here, we report the accumulation of monocyte-derived macrophages with an enrichment of fibrosis-associated gene signatures and significant similarity to macrophage populations found in IPF in the lung during sever COVID-19 (Adams et al., 2020; Ayaub et al., 2021; Morse et al., 2019; Reyfman et al., 2019) . Notably, SARS-CoV-2 was sufficient to induce a similar differentiation program in classical monocytes in vitro, indicating that viral contact may constitute a trigger for profibrotic macrophage reprogramming. These findings were corroborated by quantitative proteomics and extended to posttranslational alterations including the CEBPB isoform ratio, which has also been associated with fibrosis. In line with these findings, we observed restrictive ventilatory defects and radiographic signs of consolidation and fibrotic remodelling, and histopathology revealed myofibroblast and fibroblast expansion and pronounced ECM deposition. These findings aligned with the clinical observation that patients with COVID-19 ARDS require protracted respiratory support and ECMO therapy, and show increased mortality rates compared to other forms of ARDS. Our study describes a predominantly profibrotic profile of pulmonary macrophages in severe COVID-19, accompanied by profound fibrotic lung tissue remodeling. This is in line with previous reports of organizing pneumonia, scarring and fibrosis in patients with COVID-19 ARDS, and even in individuals with initially mild or moderate disease (Bharat et al., 2020; Combet et al., 2020; Pan et al., 2020; Schwensen et al., 2020; Spagnolo et al., 2020) .

While IPF is characterized by chronically progressive, irreversible fibrosis, COVID-19 induced fibrotic tissue remodeling occurs rapidly and is at least partially reversible in the majority of survivors. Yet, both conditions share similar epidemiological risk factors, including older age, male sex, history of cigarette smoking, and other comorbidities. Viral infections have also been repeatedly implicated in the pathogenesis of IPF and as triggers of acute exacerbations (Meneghin and Hogaboam, 2007; Molyneaux and Maher, 2013; Naik and Moore, 2010; Sheng et al., 2020; Wootton et al., 2011) . Moreover, acute exacerbations of IPF are characterized by bilateral ground glass opacities and evidence of diffuse alveolar damage, which is suggestive of viral infection and subsequently enhanced fibrosis (Collard et al., 2007 (Collard et al., , 2016 Wootton et al., 2011) . Our data reveal unexpected, common features of IPF and severe COVID-19 ARDS, namely, aberrant macrophage activation and inappropriate fibroproliferative responses in susceptible individuals (Morse et al., 2019; Schupp et al., 2015; Thompson et al., 2017) .

Monocytes and profibrotic macrophages play a critical role in the pathogenesis and progression of both ARDS and lung fibrosis (Gibbons et al., 2011; Herold et al., 2015; Misharin et al., 2017; Nouno et al., 2019; Scott et al., 2019; Thompson et al., 2017) . Circulating J o u r n a l P r e -p r o o f monocyte numbers have been proposed as prognostic biomarkers in IPF and genetic deletion of CCR2 or depletion of monocyte-derived macrophages protects mice from drug-induced lung fibrosis (Misharin et al., 2017; Moore et al., 2001; Brody et al., 2021; Teoh et al., 2020) .

Accumulation of CD163 + macrophages has been associated with poor outcome in IPF (Brody et al., 2021; Nouno et al., 2019) . CD163/LGMN-Mφ expressed high levels of Osteopontin (encoded by SPP1), a secreted ECM phosphoglycoprotein (Liaw et al., 1995) , which also doubles as a cytokine that stimulates collagen-I production in fibroblasts and exerts profibrotic functions in IPF (Pardo et al., 2005; Urtasun et al., 2012) . TGFB1 (encoding TGF-β), a master regulator of wound healing and organ fibrosis (Frangogiannis, 2020; Morse et al., 2019) , and several TGF-β-related genes, including TGFBI and NRP1 were also highly expressed in CD163/LGMN-Mφ. Macrophage-derived TGFBI promotes collagen production in fibroblasts and inhibits collagen turnover by suppressing antifibrotic MMP14 (Frangogiannis, 2020; Morse et al., 2019; Nacu et al., 2008) . Legumain (LGMN) is an asparaginyl endopeptidase involved in matrix metalloproteinases (MMP) activation, TGF-β signaling, ECM deposition, and plays a prominent role in organ fibrosis (Bai et al., 2019; Ren et al., 2020) .

LGMN is highly expressed in CD163/LGMN-Mφ and in profibrotic macrophages in IPF (Ayaub et al., 2021; Morse et al., 2019) and it was strongly induced in monocytes upon exposure to SARS-CoV-2.

We demonstrated that exposure to SARS-CoV-2, but not IAV, induces transcriptome and proteome profiles with high similarity to those of IPF-associated macrophages, and we also detected SARS-CoV-2 transcripts in pulmonary macrophages. These findings suggest that SARS-CoV-2 may directly contribute to the profibrotic macrophage phenotype in severe COVID-19. Other factors likely propagate fibrogenic macrophage responses at later stages, but fibrotic tissue states can be triggered by strong initial impulses into pathological stability and typically resolve slowly (Adler et al., 2020) . Recognition of tissue damage and uptake of apoptotic cells are known stimuli of wound healing and profibrotic responses, through the induction of TGF-β (Huynh et al., 2002) . Pulmonary macrophages in COVID-19 expressed a range of scavenger receptors and proteins involved in efferocytosis, including MRC1, CD163, TREM2, and MERTK, among others, and high levels of TGFB1 and TGFBI. Hence, SARS-CoV-2 infection induces expression of genes that may directly and indirectly promote profibrotic functions of macrophages. These damage repair responses may be beneficial to control inflammatory tissue damage. Yet, unchecked and aberrant, they may cause enhanced fibroproliferation and protracted respiratory failure in susceptible individuals. In this regard, it will be important to assess the presence of CD163/LGMN-Mφ and their fate in patients with milder forms of COVID-19.

Pulmonary sequelae of COVID-19 including fibrosis have been previously reported, but the exact disease burden remains unclear. A recent 6-month follow up of 1,733 patients previously J o u r n a l P r e -p r o o f hospitalized for COVID-19 revealed reduced median 6-min walking distance, and decreased diffusion capacity and total lung capacity, indicative of restrictive ventilatory defects. This was more pronounced following severe disease, excluding patients on ECMO or organ support . In addition, there are several reports of severe, progressive lung fibrosis following mild to moderate SARS-CoV-2 infection (Arjun et al., 2020; Combet et al., 2020; Schwensen et al., 2020) . It will be important to identify patients at risk of developing fibrotic complications of COVID-19 and to devise early intervention strategies, including potentially antifibrotic therapies (George et al., 2020) . Blockade of monocyte influx may also present an attractive strategy. On the other hand, it is clear that fibrotic lesions resolve, or partially resolve over time in patients who survive COVID-19 ARDS. The recovery phase may therefore provide a unique window to investigate molecular mechanisms of fibrosis resolution.

We combined in vivo and in vitro analyses of transcriptional and proteomic profiles in COVID-19-associated macrophages and compared these to macrophage phenotypes in IPF. Causal links between the accumulation of specific macrophage populations and fibrotic tissue remodeling is difficult to establish in an observational study. The snRNA-seq analysis and cell communication inference indicated profibrotic functions of COVID-19-associated macrophages. Additionally, recent modeling of macrophage-fibroblast cell circuits during fibrosis, predicted excessive macrophage tissue influx and a profibrotic macrophage setpoint to cause increased fibroproliferation as well as pathological fibrosis (Adler et al., 2020) . We demonstrate direct effects of SARS-CoV-2 on profibrotic macrophage programs in vitro, but the relevance of virus-macrophage interactions during COVID-19 ARDS in vivo is challenging to determine in human studies. The molecular mechanisms underlying the induction of profibrotic genes by SARS-CoV-2 remain to be investigated in greater detail.

In conclusion, we describe a profound fibroproliferative tissue response in severe COVID-19 ARDS, associated with an accumulation of monocyte-derived macrophages with significant transcriptional similarities to profibrotic macrophages in IPF. We propose that SARS-CoV-2 promotes fibrosis-associated genetic programs in macrophages, which are further sustained and enhanced by responses to extensive tissue damage. It will be important to dissect the molecular mechanisms linking viral recognition to profibrotic macrophage responses in ARDS, and in chronic organ fibrosis, as these may provide new targets for therapeutic intervention. (C) Marker gene expression and SARS-CoV-2 mRNA counts, color-coded and projected onto the UMAP embedding in panel B. Statistical significance of differential expression for each gene per cluster shown in Table S2 .

(D) Dot plot of scaled log-normalized differentially expressed marker genes of the clusters in (B). Genes color-coded by functional categories. Dot size indicates percentage of cells per cluster with any mRNAs detected, color shows z-scores of log-normalized mRNA counts. Table S2 .

(E) Relative proportions of cell types across all BAL scRNA-seq samples derived from Figure   2B and S2M ordered by increasing days post symptom onset.

(F) Heatmap displaying -log10 transformed adjusted p-values (one-sided Fisher's Exact Test) assessing the overlap between gene sets from COVID-19-associated monocyte/macrophage clusters identified in (B) (y-axis) and published transcriptional signatures of COVID-19associated monocytes/macrophages (cluster names and reference studies indicated, Table   S3 ). (D) UMAP embedding as shown in Figure 1F color-coded by donor.

(E) UMAP embedding as in Figure 1F , color-coded arcsin-transformed mean fluorescence intensity across all epitopes measured by MELC.

(F) CD163 fluorescence intensity across the different cellular populations identified by MELC as presented in Figure 1F , every dot represents one cell. The Line indicates the threshold of CD163+ and CD163-cells. (F) Heatmap displaying differential expressed (DE, FDR < 10e-15) genes between macrophage populations (as in Figure 2B ) and across the different patients analysed.

(G) UMAP as Figure 2B split by patient, color indicates macrophage clusters as in Figure 2B .

(H) Heatmap showing the mean rank of ChEA3 transcription factor enrichment. Clusters (yaxis) as in Figure 2B , transcription factors (x-axis) ordered by cluster and mean rank. Input to ChEA3 were the DE genes shown in F, TFs were selected by mean rank < 30. (O) Dot plot showing the previously identified monocyte/macrophage markers as in Figure 2F for the cell subtype labels from (L). Dot size shows the percentage of cells per cluster, color shows average expression of log-normalized mRNA counts. Figure 2B ). Violin plots are filled with color displaying cluster identity as in (D) Marker gene expression projected onto the UMAP embedding as in Figure 6B .

(E) Heatmap showing the mean rank of ChEA3 transcription factor enrichment. Clusters (yaxis) as in Figure 6B , transcription factors (x-axis) ordered by cluster and mean rank. Input to ChEA3 were the DE genes shown in Figure S6C , TFs were selected by mean rank < 35. (E) Annotated MS2 spectrum of the phosphopeptide identified from IRF7 (left) and heatmap representing the TMT reporter ion relative intensities for the specified peptide (right).

(F) Annotated MS2 spectrum of the phosphopeptide identified from CEBPB (left) and heatmap representing the TMT reporter ion relative intensities for the specified peptide (right).

(G) Secretion of selected proteins quantified by ELISA. Bars represent the mean across all corresponding measurements. Error bars represent the standard deviation. Symbols depict donor-specific measurements. All experiments were tested against mock for significance (onesided t-test, on log transformed data). Differences between SARS-CoV-2 and IAV-stimulated cells were tested for significance using a two-sided t-test. Significance reported in the figure corresponds to Benjamini-Hochberg adjusted p-values of: *; p < 10%, **; p < 5%, ***; p < 1%. Patients treated with severe COVID-19 ARDS with requirement for veno-venous vvECMO treatment, qualified for inclusion for the assessment of CT images and pulmonary gas exchange. Out of 18 identified patients, two patients were excluded from the analysis due to death less than 36h after vvECMO initiation. Information on age, sex, medication, commorbidities and outcome is provided in Table S1 .

The autopsy study was approved by the Ethics Committee of the Charité (EA 1/144/13, EA2/066/20 and EA1/075/19) and was performed in compliance with the Declaration of Helsinki. For histology, we analyzed cryopreserved lung tissue from deceased patients with COVID-19. Patients were selected from an autopsy cohort at Charité described in . Inclusion criteria were presence of cryopreserved material and detectable SARS-CoV-2 RNA load in the lung tissue. Patients with detectable tumor infiltration and one case with graft-versus-host reaction after stem cell therapy were excluded from the analysis.

Information on age, sex, medication, commorbidities is listed in Table S1 .

Cohort 2 -Aachen cohort stocks were plaque titrated in three independent experiments as described previously (Niemeyer et al., 2018) . The absence of any second site mutations was confirmed by next generation sequencing.

Approximately 1x10 (Matthaei et al., 2013; Niemeyer et al., 2018) . Virus stocks were stored at -80°C.

The samples of the central and peripheral lung from each lobe, 4% formaldehyde-fixed and paraffin-embedded (FFPE), were further processed and histologically evaluated. FFPE blocks were cut to 1 μm thick sections, deparaffinized, rehydrated, and stained with hematoxylineosin (H&E) staining according to standard protocol using an automated staining system (Tissue-Tek Prisma® Plus & Tissue-Tek Film®, Sakura).

To estimate pulmonary fibrosis, a semiquantitative score (Ashcroft Score) was used as previously described (Ashcroft et al., 1988) . Briefly, an H&E section of the lung was examined systematically at 10x magnification. Each patient was assigned a score between 0 and 8 using a predetermined scale of severity (0 = normal lung, 8 = total fibrous obliteration of the field), based on the predominant degree of fibrosis on the lung section. Fields predominantly occupied by large bronchi or vessels, or by malignant tumor deposits were not counted.

Inflammatory cells in airspaces were ignored, but organised exudate was treated as fibrosis.

Two experienced pathologists scored each case independently and a mean value was calculated from the two scores for each patient.

For immunohistochemistry (collagens I, III, IV, CD68), FFPE blocks were cut to 1 μm thin sections, deparaffinized, rehydrated and washed in phosphate-buffered saline (PBS). Slides underwent heat-induced epitope retrieval in citrate buffer (pH 6.0, Antigen Unmasking Solution, Citric Acid-Based (Vector, H-3300)), were quenched with 3% H2O2, incubated in a humidified chamber with primary antibodies (Key Resources for one hour followed by incubation with a secondary antibody (dilution 1:300 or ready-to-use, Key Resources Table) (30 minutes), followed by ABC complex (30 minutes), followed by 3-3'-Diaminobenzidine (DAB) for 10 minutes, and counterstained with methyl green. CD68-/Sm22costaining was performed accordingly with the following differences: no H2O2-blocking, ABC complex and DAB incubation were performed and slides were not counterstained with methyl green. Dilutions of primary antibodies were 1:100.After incubation of the secondary antibody (ready-to-use or dilution 1:300, Key Resources Table) DAPI was used to highlight nuclei.

To analyze Macrophage subtypes, we used the VECTRA automated quantitative pathology imaging system, and stained using our pre-established protocol as followed: slides underwent 

Immunohistochemistry slides were scanned with the 40x objective using an Aperio AT2 whole Slide Scanner (Leica Biosystems, Wetzlar, Germany). Immunohistochemistry whole slide images were evaluated using the latest stable QuPath (Bankhead et al., 2017) release (i.e. (ThermoFisher) and quality was checked using 2100 Bioanalyzer with High Sensitivity DNA kit (Agilent). Sequencing was performed in paired-end mode with S1 and S2 flow cells (2 × 50 cycles kit) using NovaSeq 6000 sequencer (Illumina).

Peripheral blood mononuclear cells were isolated by gradient centrifugation (1.077 g/ml Pancoll™, PAN Biotech) from fresh EDTA blood or buffy coats (German Red Cross Blood Transfusion Service, Berlin) of healthy donors, followed by immunomagnetic depletion of CD3 + /CD19 + /CD20 + /CD56 + /CD235a + cells using biotinylated antibodies (Biolegend) and

MagniSort™ 

Fresh frozen tissue was cut in 5 µm sections with a MH560 cryotome (ThermoFisher, Waltham, Massachusetts, USA) on cover slides (24 x 60 mm; Menzel-Gläser, Braunschweig, Germany) that had been coated with 3-aminopropyltriethoxysilane (APES). Samples were fixed for 10 minutes at room temperature (RT) with 2% paraformaldehyde (methanol-and RNAse-free; Electron Microscopy Sciences, Hatfield, Philadelphia, USA). After washing, samples were permeabilized with 0.2% Triton X-100 in PBS for 10 min at room temperature and unspecific binding was blocked with 10% goat serum and 1% BSA in PBS for at least 20 minutes. Afterwards, a fluid chamber holding 100 μl of PBS was created using "press-to-seal" silicone sheets (Life technologies, Carlsbad, California, USA; 1.0 mm thickness) with a circular cut-out (10 mm diameter), which was attached to the cover slip surrounding the sample.

MELC image acquisition was performed as previously shown (Holzwarth et al., 2018; Pascual-Reguant et al., 2021) . We generated the multiplexed histology data on a modified Toponome Image Cycler® MM3 (TIC) originally produced by MelTec GmbH & Co.KG Magdeburg, Germany (Schubert et al., 2006) . The ImageCycler is a robotic microscopic system with 3 main components: (1) an inverted widefield ( 

Samples for TEM from two deceased patients that were tested positive for SARS-CoV-2 RNA via PCR were processed as described previously (Ochs et al. 2021 

Proteomics and phosphoproteomics were prepared using a strategy adapted from Mertins et al. (Mertins et al., 2018) . Lysates were cleared via centrifugation (20,000g, 15min, 4°C) and protein content in the supernatant was measured via BCA assay (Thermo Fisher Scientific, J o u r n a l P r e -p r o o f 23225). Samples were diluted to the same protein concentration with lysis buffer (8M urea, 150mM NaCl, 50mM Tris HCl pH 8.0, 1mM EDTA, cOmplete™ Protease Inhibitor Cocktail (Roche, 11697498001), Phosphatase Inhibitor Cocktail 2 and 3 (Sigma-Aldrich, P5726 and P0044)) and subsequently reduced and alkylated via incubation with 5mM DTT and 10mM

iodoacetamide, respectively. Samples were diluted to 2M Urea with 50Mm Tris pH 8.0, then pre-treated with LysC (Wako Chemicals) at 1:50 (w/w) ratio for 2 hours at room temperature, then trypsin (Promega) was added at 1:50 (w/w) ratio and samples were digested overnight at room temperature. Digests were acidified with formic acid (FA) and centrifuged (20,000g, 15min) to remove the precipitated urea. Approximately 30μg of protein digest were desalted using STop-And-Go Extraction tips (Stage-tips) (Rappsilber et al., 2007) . 

Image pre-processing All images were aligned by cross-correlation based on the reference phase contrast image taken at the beginning of the measurement. Afterwards, each fluorescence MELC image was processed by background subtraction and illumination correction, based on the signal of the bleaching images (Schubert et al., 2006) . In order to account for slice thickness, an "Extended Depth of Field" algorithm was applied on the 3D fluorescence stack in each cycle (Pertuz et al., 2013) . Images were then normalized in Fiji (Schindelin et al., 2012) , where a rolling ball algorithm was used for background estimation, edges were removed (accounting for the maximum allowed shift during the autofocus procedure) and fluorescence intensities were stretched to the full intensity range (16 bit => 2 16 ). The 2D fluorescence images generated in this way were subsequently segmented and analyzed.

Segmentation was performed in a two-step process, a signal-classification step using Ilastik 1.3.2 (Berg et al., 2019) followed by an object-recognition step using CellProfiler 3.1.8 (Carpenter et al., 2006) , as described elsewhere (Schapiro et al., 2017) . Ilastik was used to classify pixels into three classes (nuclei, membrane, and extracellular matrix -ECM-) and to generate probability maps for each class. Classification of images regarding membranes and ECM was performed by summing up a combination of images, using markers expressed in the respective compartments, while only the DAPI signal was used to classify nuclei. The random forest algorithm (machine-learning, Ilastik) was trained by manual pixel-classification in a small region of each data-set (approx. 6% of the image). CellProfiler was subsequently used to segment the nuclei and membrane probability maps and to generate nuclei and cellular binary masks, respectively. These masks were superimposed on the individual fluorescence images acquired for each marker, in order to extract single-cell information, i.e. mean fluorescence intensity (MFI) of each marker per segmented cell.

Mean fluorescence intensities were normalized to the full 16-bit range in Fiji, brought to a 0 to 1 scale in CellProfiler and transformed using the hyperbolic arcsine (cofactor/scale argument = 0.2) prior to clustering analysis. All CD45 expressing cells were selected and data was imported into R version 3.6.3 (https://cran.r-project.org/src/base/R-3/). A total of 22 markers per cell were included in the panel, normalized by the total fluorescence intensity across all J o u r n a l P r e -p r o o f markers per cell, scaled (z-scores), and used to compute a two dimensional Uniform Manifold Approximation and Projection (McInnes et al., 2018) embedding using the R package uwot (n,neighbors = 50, n_epochs = 500, n_trees = 100, init = "pca", min.dist = -0.1, metric = "euclidean"). For unsupervised clustering, a shared nearest neighbor tree was calculated using the scran (Lun et al., 2016b) function buildSNNGraph. The Leiden algorithm (Traag et al., 2019) was applied on the graph object with the resolution parameter 0.9 and seed 1993.

Unless otherwise stated, all algorithms were used with default settings.

For Macrophage-Collagen IV distance measurements Collagen 4 layer .tif-files were converted into raster objects using the r library "raster". Euclidean distances of Cellprofiler cell coordinates to the closest Collagen IV structures were calculated with the R package "sf".

Cells were grouped into the groups "in collagen", "adjacent to collagen", and "out of collagen" by clustered pixel distances that best represented the visual localisations over all fields of view. Proportions of CD163 + and CD163macrophages per field of view and localisation were computed. Population mean rank differences were tested by paired, two-sided Wilcoxon signed rank test adjusted for multiple testing by the Bonferroni correction.

The Cell Ranger version 3.0.1 software suite was obtained from 10x Genomics. Raw sequencing data was first de-multiplexed and quality-checked using the Cell Ranger 'mkfastq'

script. For all sample libraries, alignment and transcript quantification was performed with the standard Cell Ranger 'count' script against a custom made genome reference containing the GRCh38 human genome assembly and the SARS-CoV-2 genome. Multiple datasets belonging to the same experiment were combined with the Cell Ranger 'aggr' script.

Count matrices were loaded into R and low quality transcriptomes (e.g. dead or ruptured cells)

were removed. Thresholds for the number of genes, number of unique RNA molecules (UMI) and percent mitochondrial genes for each dataset are available in 

Hashtag counts were normalized using the Seurat function NormalizeData(method = "CLR").

Cutoffs were chosen by k-means clustering of cells for each hashtag. Uniquely called hashtags were annotated with the experimental condition, double stained (doublet) and unstained (negative) cells were removed (code is available on the GitHub repository).

Donors of PBMCs were demultiplexed using the souporcell algorithm (Heaton et al., 2020) based on the BAM files & barcodes exported by CellRanger count.

Principal component analysis (PCA) was calculated for each dataset using the Seurat function RunPCA based on the highly variable genes. Batch correction (if applied) was performed during the PCA using the batchelor (Haghverdi et al., 2018) Table S3 .

Cellranger output files were loaded into R (4.0.3) using the Read10X function from Seurat.

Low quality transcriptomes were removed from further analysis by filtering for cells with at least 150 unique features and a mitochondrial gene percentage lower than 30%.

Subsequently, normalization, variable feature detection and scaling of the data were Resulting clusters were annotated to the respective monocyte/Mφ subtype according to the previously identified markers.

Scores for gene expression programs were computed using the Seurat function AddModuleScore (seed = 1993). The top 50 genes of different reference datasets were used, if the list contained less than 50 genes all of them were used as input. Statistical significance of population shifts between clusters were assessed by pairwise, one-sided (alternative = "greater"), two-sample Wilcoxon rank sum test (wilcox.test) of each cluster compared to the average.

Overrepresentation analysis of genes between two gene sets was performed by one-sided (alternative = "greater") Fisher's exact test (fisher.test). P-values were adjusted for multiple comparisons (p.adjust). All functions were used with default settings unless specified otherwise.

Statistical analysis of differential gene expression was performed using the scran function findMarkers (pval.type = "some", test.type = "wilcox", direction = "up"), the block argument was used for patients in the BAL dataset and donors in the stimulated monocytes. Genes with a FDR below 10⁻ ¹⁵ were considered differentially expressed.

Trajectories with pseudotime were computed using the slingshot (Street et al., 2018) 

Refined cell type annotation was performed on the macrophage, and mesenchymal (fibroblast, SMC, and pericyte) clusters. They were each subsetted from the entire dataset and reprocessed to find underlying subclusters by repeating the previous steps of CCA, PCA, UMAP, and clustering on the selected cells. Markers from the scRNA-seq BAL dataset were used to annotate the different macrophages, while mesenchymal markers from previously published scRNA-seq lung atlases were applied to identify fibroblasts, SMC, and pericytes (Adams et al., 2020; Reyfman et al., 2019) .

Potential cell-cell interactions between the different subclusters of macrophages and mesenchymal cells were identified using CellChat v0.5.5 (Jin et al., 2021) . Differential interactions between patient groups were calculated using mergeCellChat() and

compareInteractions() functions iteratively per comparison. Intercellular communication networks are weighted directed graphs composed of significant interactions between cell groups, where "interaction strength" is defined as the communication probability of the computed networks (Jin et al., 2021) . Differentially enriched interaction pathways were determined for early and late postmortem SARS-CoV-2 cases by using the rankNet() function.

Significance was determined by the function by performing a paired Wilcoxon test. Information flow is the overall communication probability, where it is the summation of the probability among all pairs of cell groups in the inferred network.

Single cells from this study and three previous studies were integrated into a single embedding. Briefly, macrophage cells from (Adams et al., 2020) and ( infections), with macrophage annotations and balanced condition, respectively. These cells were integrated with 7,503 monocyte-derived cells from this study. The integration of the three datasets was done using single-cell variational inference (scVI) as implemented scvi-tools (version 0.6.7) (Lopez et al., 2018) , using patient identifiers in Adams (one per patient), sample identifiers in Morse (one or more per patient), and patient identifiers in (Bharat et al., 2020) (one per patient) as batch covariates, respectively. scVI was chosen for integration since it was a scalable top performer in a recent batch integration benchmark (Luecken et al., 2020) .

The network architecture had the following parameters: n_latent=30, n_hidden=128, and n_layers=2. We trained this network for 400 epochs and used the latent representation as a low dimensional embedding to compute a k-nearest neighbor graph for the integrated cells with k=15, using SCANPY (Wolf et al., 2018) (version 1.6.0; anndata version 0.7.4) and calculate a UMAP layout (McInnes et al., 2018) .

To assess the similarity of monocyte-derived macrophages from patients with COVID-19 to these cells from other diseases, we mapped condition labels (i.e., fibrosis, COPD, and control) from our reference to the COVID-19 monocyte-derived macrophages. To reach a robust result, we treated the (Bharat et al., 2020) study as a replicate of this study and thus repeated the same experiment with each dataset. Thus, cells from (Bharat et al., 2020) , were held out for the analysis of cells from this study, and vice versa for the analysis of cells from (Bharat et al., 2020) . Specifically, we mapped condition labels onto monocyte-derived macrophages from either COVID-19 study via local majority voting: briefly, based on the kNN graph built from the joint embedding, all nearest neighbors from other non-COVID-19 studies were retrieved for each monocyte-derived cell from the study. The most common condition label (IPF/control/COPD) across these neighbors was then projected onto the cell. We did not consider the monocyte-derived macrophage "Low Quality" category for this analysis, to allow easier interpretation. Furthermore, as cells from COPD were underrepresented in the integrated dataset despite previous down-sampling, we did not consider cells assigned to J o u r n a l P r e -p r o o f COPD for further analysis as these would be underrepresented purely due to the background distribution. To ensure a completely separate analysis of both COVID-19 studies, we annotated cells from our study after removing (Bharat et al., 2020) cells from the integrated embedding and recalculated nearest neighbors, and vice versa for mapping cells in (Bharat et al., 2020) .

To assess the enrichment of specific condition labels for each monocyte-derived macrophage subtype, we calculated the enrichments of each monocyte-derived macrophage and condition combination using 2 x 2 contingency tables. Significance of observed odds ratios were calculated using Fisher's exact tests, one-tailed, and adjusting p-values using Benjamini

Hochberg's procedure (Benjamini and Hochberg, 1995) .

RAW files were analyzed using MaxQuant (Tyanova et al., 2016) Figure 3A of (Ayaub et al., 2021) . All gene set distributions were tested for average upregulation for each timepoint compared to all other quantified proteins using a one-sided wilcoxon rank sum test using the wilcox.test function implemented in R (Version 3.6.3).

Supplemental Information Table S1 . Cohort Details, related to Figures 1,2 ,3,4,5 and S1,S2,S3,S4,S5. 

Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis

rgl: 3D Visualization Using OpenGL

Principles of Cell Circuits for Tissue Repair and Fibrosis

Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage

Case report of severe pulmonary fibrosis as a sequelae of COVID-19 infection

MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages

Simple method of estimating severity of pulmonary fibrosis on a numerical scale

Single cell RNA-seq and mass cytometry reveals a novel and a targetable population of macrophages in idiopathic pulmonary fibrosis

Macrophage-Derived Legumain Promotes Pulmonary Hypertension by Activating the MMP (Matrix Metalloproteinase)-2/TGF (Transforming Growth Factor)-β1 Signaling

QuPath: Open source software for digital pathology image analysis

Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

ilastik: interactive machine learning for (bio)image analysis

Lung transplantation for patients with severe COVID-19

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

The dynamic proteome of influenza A virus infection identifies M segment splicing as a host range determinant

Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial

Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19

ggalluvial: Layered Grammar for Alluvial Plots

mRNAs, proteins and the emerging principles of gene expression control

Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials

Translational control of C/EBPalpha and C/EBPbeta isoform expression

Ggnewscale: Multiple Fill and Colour Scales in "Ggplot2

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

CellProfiler: image analysis software for identifying and quantifying cell phenotypes

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis

Influenza virus replication in macrophages: J o u r n a l P r e -p r o o f balancing protection and pathogenesis

Acute exacerbations of idiopathic pulmonary fibrosis

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

COVID-19 and myeloid cells: complex interplay correlates with lung severity

Neuropilin-1 is a host factor for SARS-CoV-2 infection

A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the sam mRNA

COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?

The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material

Transforming growth factor-β in tissue fibrosis

viridis: Default Color Maps from "matplotlib

SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals

Scvi-tools: A library for deep probabilistic analysis of single-cell omics data

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis

Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia

Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors

S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis

Array programming with NumPy

Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis

Temporal dynamics in viral shedding and transmissibility of COVID-19

Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes

Fibrosis: from mechanisms to medicines

Biology and pathology of fibroproliferation following the acute respiratory distress syndrome

Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports

Influenza virus-induced lung injury: pathogenesis and implications for treatment

Geographic Data Analysis and Modeling

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Multiplexed fluorescence microscopy reveals heterogeneity among stromal cells in mouse bone marrow sections

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage

Matplotlib: A 2D Graphics Environment

Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation

Inference and analysis of cell-cell communication using CellChat

Estimating infectiousness throughout SARS-CoV-2 infection course

A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocytederived alveolar macrophages

Package "ggpubr

ChEA3: transcription factor enrichment analysis by orthogonal omics integration

Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity

SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant

Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro

Deep generative modeling for single-cell transcriptomics

Benchmarking atlas-level data integration in single-cell genomics

SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells

Pooling across cells to normalize single-cell RNA sequencing data with many zero counts

A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor

Highly pathogenic H5N1 influenza A virus strains provoke heterogeneous IFN-α/β responses that distinctively affect viral propagation in human cells

UMAP: Uniform Manifold Approximation and Projection

COVID-19: consider cytokine storm syndromes and immunosuppression

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses

Infectious disease, the innate immune response, and fibrosis

Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry

Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection

Monocytederived alveolar macrophages drive lung fibrosis and persist in the lung over the life span

The role of infection in the pathogenesis of idiopathic pulmonary fibrosis

Protection from pulmonary fibrosis in the absence of CCR2 signaling

Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis

Macrophages produce TGF-beta-induced (betaig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts

Viral infection and aging as cofactors for the development of pulmonary fibrosis

The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species

Elevation of pulmonary CD163 and CD204 macrophages is associated with the clinical course of idiopathic pulmonary fibrosis patients

Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient

The jsonlite Package: A Practical and Consistent Mapping Between JSON Data and R Objects

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China

Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis

Multiplexed histology analyses for the phenotypic and spatial characterization of human innate lymphoid cells

A randomized trial of otilimab in severe COVID-19 pneumonia (OSCAR) (medRxiv)

Simple Features for R: Standardized Support for Spatial Vector Data

Generation of all-in-focus images by noise-robust selective fusion of limited depth-of-field images

A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression

Pheatmap: pretty heatmaps. R Package Version 1

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips

R: A language and environment for statistical computing

R: A language and environment for statistical computing

Dexamethasone in Hospitalized Patients with Covid-19 -Preliminary Report

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections

Legumain promotes fibrogenesis in chronic pancreatitis via activation of transforming growth factor β1

Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Osteopontin in macrophage function

Quantitative Proteomic Approach Identifies Vpr Binding Protein as Novel Host Factor Supporting Influenza A Virus Infections in Human Cells

Identification of an atypical monocyte and committed progenitor involved in fibrosis

histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data

Fiji: an open-source platform for biological-image analysis

Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages

Analyzing proteome topology and function by automated multidimensional fluorescence microscopy

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis

Fatal pulmonary fibrosis: a post-COVID-19 autopsy case

Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study

Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-Analysis

Is a "Cytokine Storm" Relevant to COVID-19?

Pulmonary fibrosis secondary to COVID-19: a call to arms?

SARS-CoV-2 infection dynamics in lungs of African green monkeys

Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys

Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics

Comprehensive Integration of Single-Cell Data

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19

Visualizing large-scale and high-dimensional data

Blood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF registry

Acute Respiratory Distress Syndrome

From Louvain to Leiden: guaranteeing well-connected communities

rawDiag: An R Package Supporting Rational LC-MS Method Optimization for Bottomup Proteomics

The MaxQuant computational platform for mass spectrometry-based shotgun proteomics

Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling

SciPy 1.0: fundamental algorithms for scientific computing in Python

Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

A smart local moving algorithm for large-scale modularity-based community detection

seaborn: statistical data visualization

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis

httr: Tools for Working with URLs and HTTP. R Package Version 0

ggplot2: Elegant Graphics for Data Analysis

Stringr: Simple, consistent wrappers for common string operations. R Package Version 1

Tidy Messy Data

Read Rectangular Text Data

A Grammar of Data Manipulation

SCANPY: large-scale single-cell gene expression data analysis

Virological assessment of hospitalized patients with COVID-2019

Viral infection in acute exacerbation of idiopathic pulmonary fibrosis

Macrophages in Tissue Repair, Regeneration, and Fibrosis

Distinct Profiles of CD163-Positive Macrophages in Idiopathic Interstitial Pneumonias

CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients

clusterProfiler: an R package for comparing biological themes among gene clusters

The members of the DeCOI network are listed in the supplement. The authors are grateful to all patients and their relatives for consenting to biosampling and data collection. COVID-19 research at Charité -Universitätsmedizin Berlin was facilitated by the PA-COVID-19 study group .